Puretech Health PLC (PRTC) Earns Buy Rating from Liberum Capital

Liberum Capital reiterated their buy rating on shares of Puretech Health PLC (LON:PRTC) in a research note released on Wednesday. They currently have a GBX 248 ($3.21) price objective on the stock.

Several other equities research analysts have also issued reports on PRTC. Peel Hunt restated a buy rating and set a GBX 259 ($3.35) price target on shares of Puretech Health PLC in a research note on Friday, March 24th. Numis Securities Ltd reiterated a buy rating and issued a GBX 220 ($2.85) price objective on shares of Puretech Health PLC in a research note on Friday, March 24th. Jefferies Group LLC reiterated a buy rating and issued a GBX 255 ($3.30) price objective on shares of Puretech Health PLC in a research note on Thursday, April 6th. Finally, N+1 Singer reiterated a buy rating on shares of Puretech Health PLC in a research note on Thursday, April 6th. Five analysts have rated the stock with a buy rating, The stock presently has a consensus rating of Buy and a consensus price target of GBX 252.80 ($3.27).

Shares of Puretech Health PLC (LON:PRTC) opened at 127.62 on Wednesday. Puretech Health PLC has a 52 week low of GBX 110.00 and a 52 week high of GBX 170.00. The company has a 50 day moving average price of GBX 118.47 and a 200 day moving average price of GBX 118.00. The company’s market capitalization is GBX 297.00 million.

ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by Ticker Report and is owned by of Ticker Report. If you are viewing this piece of content on another website, it was illegally copied and reposted in violation of United States & international trademark & copyright law. The legal version of this piece of content can be accessed at https://www.tickerreport.com/banking-finance/2722274/puretech-health-plc-prtc-earns-buy-rating-from-liberum-capital.html.

Puretech Health PLC Company Profile

PureTech Health plc is a cross-disciplinary healthcare company. The Company operates through two segments: growth stage businesses and project phase businesses. Businesses in the growth stage businesses segment are those whose activities focus on developing products to solve healthcare problems in varied markets.

Analyst Recommendations for Puretech Health PLC (LON:PRTC)

Receive News & Ratings for Puretech Health PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Puretech Health PLC and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.